Curavit Clinical Research
Joel Morse is the co-founder and CEO of Curavit Clinical Research. Joel has also served on the board of trustees for the American University in Bulgaria and was the chairman of the finance committee in 2014. Prior to their work with Curavit, Joel was the CEO and co-founder of C3i Solutions and a senior manager at American Express.
Joel Morse studied mechanical engineering at Tufts University, where they graduated magna cum laude with a Bachelor of Science. Joel then attended Columbia University in the City of New York, where they earned a Master of Business Administration with high honors in international business and finance. Joel Morse also completed courses in physics at St. Paul's School Advanced Studies Program.
Some direct reports include Pam Diamond - Co-Founder & Chief Medical Officer, Dave Hanaman - Co-Founder, President & Chief Commercial Officer, and Chris O'Shaughnessy - VP, Business Development.
This person is not in any offices
Curavit Clinical Research
Curavit is a “Virtual CRO" that designs and executes decentralized - or “virtual” - clinical trials. Curavit leverages emerging technologies in digital health, cloud computing, and data science to recruit, engage, and monitor diverse patient populations from wherever they live, work, or study; eliminating the need for physical infrastructure and travel, while increasing data quality.